Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Cash from Investing Activities (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Cash from Investing Activities readings, the most recent being $2.8 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 179.94% to $2.8 million in Q1 2026 year-over-year; TTM through Jan 2026 was $312015.0, a 92.89% decrease, with the full-year FY2025 number at -$1.5 million, down 7.75% from a year prior.
  • Cash from Investing Activities hit $2.8 million in Q1 2026 for Pharma-Bio Serv, up from -$856665.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7.3 million in Q4 2023 to a low of -$8.2 million in Q1 2023.
  • Median Cash from Investing Activities over the past 5 years was -$2087.0 (2022), compared with a mean of -$252830.7.
  • The widest YoY moves for Cash from Investing Activities: up 65099.47% in 2023, down 1199309.94% in 2023.
  • Pharma-Bio Serv's Cash from Investing Activities stood at -$12137.0 in 2022, then soared by 60469.54% to $7.3 million in 2023, then crashed by 97.66% to $171532.0 in 2024, then plummeted by 599.42% to -$856665.0 in 2025, then soared by 422.97% to $2.8 million in 2026.
  • The last three reported values for Cash from Investing Activities were $2.8 million (Q1 2026), -$856665.0 (Q4 2025), and $1.6 million (Q3 2025) per Business Quant data.